Pulmonary Disease Doctors in Harbor City, CA Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Randel R. King, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111

Dr. Lawrence R Tom, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 424-251-7140

Dana K Loo, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111

Yossef Aelony, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111

Sunit D. Mistry, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111

News Archive

Investment report on Radient Pharmaceuticals from StockPreacher.com

StockPreacher.com announces an investment report featuring Radient Pharmaceuticals Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Smokers who switch to low-nicotine cigarettes find difficult to curb smoking habits in the long term

Smokers who successfully lowered their nicotine intake when they were switched to low-nicotine cigarettes were unable to curb their smoking habits in the long term, according to a study by researchers at UCSF and San Francisco General Hospital and Trauma Center.

Longer looks: 'Abandoning' patients; commiting people with mental illness; treating PTSD

For years I had tried and failed to understand why so many of my physician colleagues persisted in ordering tests, procedures, and treatments that seemed to provide no benefit to patients and even risked harming them.

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing.

Read more Medical News

› Verified 9 days ago